AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
-58.9%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$29.9M
AUM Growth
+$29.9M
(-85%)
Cap. Flow
-$172M
Cap. Flow
% of AUM
-576.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$27.2M |
Top Sells
| 1 |
Pulmonx
LUNG
|
$36.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $27.2M | 91.01% | +1,265,631 | New | +$27.2M |
|
|
GNCA
2
DELISTED
Genocea Biosciences, Inc.
GNCA
| $878K | 2.94% | 375,000 | – | – |
|
3
Synlogic
SYBX
$17M
| $801K | 2.68% | 205,906 | – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $676K | 2.26% | 400,000 | – | – |
|
|
5
Pulmonx
LUNG
$69.7M
| $199K | 0.67% | 4,521 -828,812 | -99% | -$36.5M |
|
|
ACGN
6
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $68K | 0.23% | 56,250 | – | – |
|
|
NBRV
7
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $62K | 0.21% | 45,849 | – | – |
|